60 DEGREES PHARMACEUTICALS, INC. - 8-K Filing
Company prepares to submit statistical analysis plan for interim trial of tafenoquine in severe babesiosis patients. (Items: 8.01 Other Events On July 7, 2026, the Company prepared, and as of the date of this notice was preparing for submission to the U)
Tickers: $SXTP